Pulling SEC filings + quote and writing the call…

Gyrodyne, LLC
Next earnings Aug 6, 2026
Sub-scale real-estate liquidation play trading ~half of book, but the value catalyst is stuck in Article 78 litigation and the data is thin.
Market cap $13.5M · 2026-07-04
Gyrodyne isn't a going-concern operator to be valued on earnings — the 10-K states plainly it is executing a "strategic plan of positioning our remaining properties for sale at enhanced values and making distributions to our shareholders." So the only question that matters is NAV versus price. On the provided FY2025 balance sheet, total assets are $58.7M against total liabilities of $32.8M, implying roughly $25.9M of net book equity; against a $13.5M market cap (2.20M shares × $6.13) the stock trades near half of depreciated book. For a liquidation vehicle whose entire thesis is realizing property value at or above carrying cost, that discount is the source of any upside — and it's a real margin of safety, which is why this is a hold and not an outright avoid.
But the catalyst is jammed. The value-enhancement rests on entitlements: the Town of Smithtown Planning Board granted preliminary approval to subdivide Flowerfield into eight lots in March 2022, and the Village of Head of the Harbor immediately filed an Article 78 proceeding to annul it — litigation that the MD&A still lists as a live risk in the FY2025 filing, i.e. roughly four years unresolved. Management concedes it "cannot assure you that we will realize growth in the value of our Flowerfield and Cortlandt Manor properties that exceeds our land entitlement costs or any at all." Meanwhile the clock and the balance sheet work against holders: cash fell 23.2% to $4.53M, total liabilities rose 26.0% to $32.8M in a single year, and the operating footprint is tiny — two developed properties, 161,430 sq ft, 82% leased to 31 tenants. Leases representing 52.18% of gross annual rent expire in 2026, adding near-term income risk on top of the entitlement overhang.
Is GYRO a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY14 |
|---|---|
| Revenue | $2.80M |
| Gross profit | — |
| Operating income | — |
| Net income | -$3.11M |
| Diluted EPS | -$2.09 |
| Net margin | -111.0% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q1'26: liquidation ongoing, portfolio 82% leased, cash burn continues
FY25: liabilities +26%, cash -23%; Article 78 suit still stalls Flowerfield sale
Entered new material definitive agreement (item 1.01) — advances property monetization
Q3'25: liquidation continues, portfolio steady at ~82% leased
Annual meeting voting results reported (item 5.07); routine governance
Reg FD investor update/press release (item 7.01); no financial commitment
Annual meeting proxy; board election/governance items up for shareholder vote
Annual meeting proxy; board election/governance items up for shareholder vote
Q2'25: steady leasing, awaiting entitlement and sale progress
Sources: SEC EDGAR (CIK 0001589061, latest 10-Q filed 2026-05-13) · EODHD · Proprietary analysis · as of 7/4/2026, 5:23:17 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 1:23 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2025-09-08 | TOWERVIEW LLC 10% owner | Sell | 1.97K @ $12.55 | $24.8K |
| 2025-08-04 | TOWERVIEW LLC 10% owner | Sell | 1.22K @ $12.10 | $14.7K |
| 2024-10-21 | TOWERVIEW LLC 10% owner | Sell | 350.00 @ $10.55 | $3.69K |
| 2024-10-18 | TOWERVIEW LLC 10% owner | Sell | 3.27K @ $11.75 | $38.4K |
| 2024-10-18 | TOWERVIEW LLC 10% owner | Sell | 3.38K @ $11.10 | $37.6K |
| 2024-08-09 | TOWERVIEW LLC 10% owner | Buy | 1.00K @ $7.77 | $7.77K |
| 2024-05-02 | TOWERVIEW LLC 10% owner | Buy | 1.85K @ $7.80 | $14.4K |
| 2024-05-01 | TOWERVIEW LLC 10% owner | Buy | 424.00 @ $7.83 | $3.32K |
| 2024-04-16 | TOWERVIEW LLC 10% owner | Buy | 2.43K @ $7.84 | $19.1K |
| 2024-04-01 | LAMB PAUL L Director | Sell | 4.37K @ $7.99 | $34.9K |
| 2024-03-12 | LOEB JAN H Director | Acquired (J) | 3.63K @ $8.00 | $29.1K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
1195 tracked peers · median